ResMed targets 59-60% gross margins and expanded global reach for AirSense 11
Q2 2025 Management View CEO Michael Farrell reported 10% global revenue growth, driven by demand across the sleep health, ...
ResMed stock holds as Oppenheimer maintains Perform rating
Oppenheimer analysts maintained a Perform rating on ResMed (NYSE:RMD) following the company's financial results for the ...
The Financial Express24d
ResMed launches new device for patients of sleep apnea in India
ResMed on Tuesday announced that it has launched AirSense 11 in India. According to the company’s statement, it is the next-generation Continuous Positive Airway Pressure (CPAP) device designed ...
fnarena2d
ResMed: Another Positive Quarterly Surprise?
UBS makes a similar comment, stating ResMed shares are trading at 23x FY26 earnings. Although this represents a 40% premium ...
Business Insider5y
My dad can manage his sleep apnea better now with this $335 automatic mask cleaning system
One of the most common treatments for obstructive sleep apnea is continuous positive airway pressure (CPAP) applied by ... but there are also bundles for ResMed AirSense 10 ($339), Fisher ...